UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
------------------
For the month of September 2004
Commission File Number: 001-31368
SANOFI-AVENTIS
(Translation of registrant's name into English)
174, avenue de France, 75013 Paris, FRANCE
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.
Form 20-F [X] Form 40-F [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1):_____
Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7):_____
Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the information to
the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of
1934.
Yes [ ] No [X]
If "Yes" marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2(b): 82-________
This Report on Form 6-K shall be deemed to be incorporated by reference
into Sanofi-Aventis' (formerly known as Sanofi-Synthelabo) Registration
Statement on Form F-4 (Registration No. 333-112314), as post-effectively amended
and declared effective on May 13, 2004 by the United States Securities Exchange
Commission, and the related prospectus, dated April 9, 2004, and the prospectus
supplement, dated May 27, 2004, each filed pursuant to Rule 424(b) under the
United States Securities Act of 1933, as amended, and shall be part thereof from
the date on which this Report is filed, to the extent not superseded by
documents or reports subsequently filed or furnished.
On September 16, 2004, Sanofi-Aventis (formerly known as
Sanofi-Synthelabo) issued the two press releases attached hereto as Exhibit 99.1
and Exhibit 99.2, each of which is incorporated herein by reference.
EXHIBIT LIST
Exhibit No. Description
---------- -----------
Exhibit 99.1 Press Release, dated September 16, 2004, announcing definitive
results of the French, U.S. and German Offers after the
subsequent offering periods
Exhibit 99.2 Press Release, dated September 16, 2004, announcing the new logo
of Sanofi-Aventis
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Dated: September 16, 2004 SANOFI-AVENTIS
By: /s/ JEAN-CLAUDE LEROY
---------------------------------
Name: Jean-Claude Leroy
Title: Senior Vice President &
Chief Financial Officer
EXHIBIT INDEX
Exhibit No. Description
----------- -----------
Exhibit 99.1 Press Release, dated September 16, 2004, announcing definitive
results of the French, U.S. and German Offers after the
subsequent offering periods
Exhibit 99.2 Press Release, dated September 16, 2004, announcing the new logo
of Sanofi-Aventis